IFN-α intracellular expression in different cell populations: percentage among IFN-α+ splenocytes
| . | Patient O . | Patient M . | Patient Q . | Patient R . | Patient J . |
|---|---|---|---|---|---|
| BDCA4/CD123+ pDCs | 0.85 | 0.72 | 0.02 | 3.11 | 0.16 |
| BDCA1+ mDCs | 0.05 | 0.14 | 0.36 | 1.37 | — |
| BDCA3+ mDCs | 0.46 | 0.85 | — | — | — |
| BDCA1+ BDCA3+ mDCs | 0.22 | 0.14 | — | — | — |
| CD14+ monocytes/macrophages | 3.94 | 7.10 | 1.12 | 0.65 | — |
| CD19+ B lymphocytes | 8.26 | 19.20 | 38.13 | 78.39 | 39.26 |
| CD3+ T lymphocytes | 42.91 | 34.07 | — | — | 16.18 |
| CD56+ CD16+ CD3− NK cells | 13.37 | 0.17 | — | — | — |
| Total | 70.06 | 62.39 | 39.63 | 83.52 | 63.51 |
| . | Patient O . | Patient M . | Patient Q . | Patient R . | Patient J . |
|---|---|---|---|---|---|
| BDCA4/CD123+ pDCs | 0.85 | 0.72 | 0.02 | 3.11 | 0.16 |
| BDCA1+ mDCs | 0.05 | 0.14 | 0.36 | 1.37 | — |
| BDCA3+ mDCs | 0.46 | 0.85 | — | — | — |
| BDCA1+ BDCA3+ mDCs | 0.22 | 0.14 | — | — | — |
| CD14+ monocytes/macrophages | 3.94 | 7.10 | 1.12 | 0.65 | — |
| CD19+ B lymphocytes | 8.26 | 19.20 | 38.13 | 78.39 | 39.26 |
| CD3+ T lymphocytes | 42.91 | 34.07 | — | — | 16.18 |
| CD56+ CD16+ CD3− NK cells | 13.37 | 0.17 | — | — | — |
| Total | 70.06 | 62.39 | 39.63 | 83.52 | 63.51 |
— indicates not applicable.